{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif5be7kfsr5xlenm7enwlshf3z5gx2crbt2htyalecptikmqwud6m",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3me6dld4aahf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifmsp7kxjk2tnwzxkmdc2nifcw4vyil53mhjxo4izthf47kitxcga"
    },
    "mimeType": "image/jpeg",
    "size": 47944
  },
  "path": "/pharmalot/2026/02/05/novo-weight-obesity-wegovy-hims-compounding-telehealth/?utm_campaign=rss",
  "publishedAt": "2026-02-05T20:51:10.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "Novo Nordisk",
    "Obesity",
    "Pharmaceuticals",
    "STAT+",
    "Telehealth",
    "weight loss"
  ],
  "textContent": "Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting the drugmaker to accuse the telehealth platform of “illegal…",
  "title": "STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill",
  "updatedAt": "2026-02-06T00:17:24.000Z"
}